Nevertheless, the investigation of pathogenic cytokines (such as TNF) has led to the development of anti-TNF therapy for patients with debilitating chronic inflammatory diseases, such as rheumatoid arthritis [167]. This evidence concerns the gene TNF and rheumatoid arthritis.